Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Wave Life Sciences Ltd. | 39,000 | reported | 05 Aug 2019 | tx 3+64,000 |
| X4 Pharmaceuticals, Inc | 25,337 | reported | 16 May 2025 | tx 13+1,646,194−50,543 |
| AMICUS THERAPEUTICS, INC. | 25,000 | reported | 01 Jun 2015 | tx 2+75,000 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 16 May 2025 | PURCHASE | X4 Pharmaceuticals, Inc | 1,032 | 2.48 USD | |
| 17 May 2024 | PURCHASE | X4 Pharmaceuticals, Inc | 21,646 | 0.68 USD | |
| 15 Nov 2024 | PURCHASE | X4 Pharmaceuticals, Inc | 13,404 | 0.34 USD | |
| 12 Feb 2025 | GRANT_AWARD | X4 Pharmaceuticals, Inc | 600,000 | 0.00 USD | |
| 23 Jan 2025 | GRANT_AWARD | X4 Pharmaceuticals, Inc | 74,773 | 0.00 USD | |
| 24 Jan 2025 | SALE | X4 Pharmaceuticals, Inc | 29,159 | 0.45 USD | |
| 07 Oct 2024 | SALE | X4 Pharmaceuticals, Inc | 11,127 | 0.58 USD | |
| 04 Oct 2024 | GRANT_AWARD | X4 Pharmaceuticals, Inc | 34,946 | 0.00 USD | |
| 13 Feb 2024 | GRANT_AWARD | X4 Pharmaceuticals, Inc | 523,414 | 0.00 USD | deriv |
| 01 Nov 2023 | SALE | X4 Pharmaceuticals, Inc | 10,257 | 0.73 USD | |
| 31 Oct 2023 | GRANT_AWARD | X4 Pharmaceuticals, Inc | 34,947 | 0.00 USD | |
| 03 Nov 2022 | GRANT_AWARD | X4 Pharmaceuticals, Inc | 341,000 | 1.89 USD | deriv |
| 05 Aug 2019 | GRANT_AWARD | Wave Life Sciences Ltd. | 35,000 | 0.00 USD | |
| 05 Aug 2019 | GRANT_AWARD | Wave Life Sciences Ltd. | 4,000 | 0.00 USD | |
| 05 Aug 2019 | GRANT_AWARD | Wave Life Sciences Ltd. | 25,000 | 0.00 USD | deriv |
| 01 Jun 2015 | GRANT_AWARD | AMICUS THERAPEUTICS, INC. | 25,000 | 0.00 USD | |
| 01 Jun 2015 | GRANT_AWARD | AMICUS THERAPEUTICS, INC. | 50,000 | 0.00 USD | deriv |